Robotics and future technical developments in pediatric urology.


Journal

Seminars in pediatric surgery
ISSN: 1532-9453
Titre abrégé: Semin Pediatr Surg
Pays: United States
ID NLM: 9216162

Informations de publication

Date de publication:
Aug 2021
Historique:
entrez: 20 8 2021
pubmed: 21 8 2021
medline: 29 10 2021
Statut: ppublish

Résumé

Minimally invasive surgery (MIS) has represented the main innovation in the field of pediatric surgery and urology over the last 30 years. Pediatric MIS is a wide field, ranging from the standard laparoscopic surgery using 3-mm ports to robotics mainly adopted for pediatric urology indications. The aim of this paper was to summarize the current status of robotic surgery in pediatric urology and to evaluate possible future technical developments for this technique. In pediatric urology, many procedures are challenged by the narrow working space available in smaller children, the difficulty to perform complex and long suture lines to repair complex urinary malformations, and the challenge to remove renal or adrenal tumors. The main characteristic of robotic surgery is that the robotic instruments inserted into the abdominal cavity are remotely controlled by the surgeon, who is sitting at a console next to the patient or even far away, avoiding human tremor during complex suturing. Due to the magnification of the operative field view and the six degrees of freedom of the robotic instruments compared to conventional laparoscopic instruments, providing enhanced 3D vision and improved surgeon ergonomics, robot-assisted surgery appears to be beneficial over conventional MIS, especially in complex reconstructive procedures. Currently, there are two robotic systems available on the market and certified for robotic surgery in children: the DaVinci (Intuitive Surgical, since 2001) and Senhance (Transenterix, since 2020). However, almost the totality of papers published in the international literature are focused on robotic procedures using the DaVinci platform. Analyzing the current literature, there is no evidence about the indications where robotics are preferable to conventional MIS approaches. Currently, the main indications of robotic surgery in pediatric urology are: pyeloplasty for ureteropelvic junction obstruction (UPJO), ureteral reimplantation according to Lich Gregoire technique, Mitrofanoff procedure, nephrectomy or partial nephrectomy for oncological indications, removal of renal cysts, bladder neck reconstruction or removal of urinary tract stones. The future developments in this field are certainly represented by intraoperative use of indocyanine green (ICG) fluorescence imaging that permits to have a better vision of vascular anatomy or clearly identify nodes in case of tumors, and by development of 5G technology. The main limitation of robotic surgery today remains the excessive cost of the machine itself and the limited lifespan of robotic instruments. We believe that robotic surgery will surely represent the new field of development in pediatric surgery, but its widespread application will depend on the introduction of new robotic platforms in the market, that will certainly low the costs, and also to the development of smaller size instruments more suitable for pediatric use.

Identifiants

pubmed: 34412879
pii: S1055-8586(21)00070-6
doi: 10.1016/j.sempedsurg.2021.151082
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151082

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Ciro Esposito (C)

Pediatric Surgery Unit, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy. Electronic address: ciroespo@unina.it.

Giuseppe Autorino (G)

Pediatric Surgery Unit, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy.

Marco Castagnetti (M)

Division of Pediatric Urology, Medical University of Padua, Padua, Italy.

Mariapina Cerulo (M)

Pediatric Surgery Unit, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy.

Vincenzo Coppola (V)

Pediatric Surgery Unit, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy.

Roberto Cardone (R)

Pediatric Surgery Unit, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy.

Giorgia Esposito (G)

Pediatric Surgery Unit, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy.

Rachele Borgogni (R)

Pediatric Surgery Unit, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy.

Maria Escolino (M)

Pediatric Surgery Unit, Federico II University of Naples, Via Pansini 5, 80131 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH